Modified vacuum-assisted closure (EndoVAC) therapy for treatment of pharyngocutaneous fistula: Case series and a review of the literature.
head and neck cancer
laryngectomy
negative-pressure wound therapy
radiochemotherapy
salvage surgery
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
23
01
2021
received:
08
12
2020
accepted:
16
03
2021
pubmed:
9
4
2021
medline:
11
8
2021
entrez:
8
4
2021
Statut:
ppublish
Résumé
Pharyngocutaneous fistula is a potential life-threatening complication following head and neck surgery. There is only limited evidence about the efficacy of vacuum-assisted closure (VAC) therapy and endoscopic vacuum-assisted closure (EndoVAC) therapy for the treatment of pharyngocutaneous fistulas. In this article, we report on a consecutive case series of six male patients with pharyngocutaneous fistula treated with a modified outside-in EndoVAC technique. We also present a review of the current related literature. EndoVAC therapy alone was successful in five of the six patients (83.3%) with a median duration of EndoVAC therapy of 18.5 days (range: 7 to 32 days) and a median number of EndoVAC sponge changes of 4 (range: 1 to 9 changes). One patient needed additional reconstructive surgery after prior radiochemotherapy and jejunal transfer. No treatment-related complications were observed. EndoVAC therapy is an easy-to-perform, safe procedure for the treatment of pharyngocutaneous fistulae.
Sections du résumé
BACKGROUND
Pharyngocutaneous fistula is a potential life-threatening complication following head and neck surgery. There is only limited evidence about the efficacy of vacuum-assisted closure (VAC) therapy and endoscopic vacuum-assisted closure (EndoVAC) therapy for the treatment of pharyngocutaneous fistulas.
METHODS
In this article, we report on a consecutive case series of six male patients with pharyngocutaneous fistula treated with a modified outside-in EndoVAC technique. We also present a review of the current related literature.
RESULTS
EndoVAC therapy alone was successful in five of the six patients (83.3%) with a median duration of EndoVAC therapy of 18.5 days (range: 7 to 32 days) and a median number of EndoVAC sponge changes of 4 (range: 1 to 9 changes). One patient needed additional reconstructive surgery after prior radiochemotherapy and jejunal transfer. No treatment-related complications were observed.
CONCLUSION
EndoVAC therapy is an easy-to-perform, safe procedure for the treatment of pharyngocutaneous fistulae.
Identifiants
pubmed: 33830587
doi: 10.1002/hed.26684
pmc: PMC9542148
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2377-2384Informations de copyright
© 2021 The Authors. Head & Neck published by Wiley Periodicals LLC.
Références
Laryngorhinootologie. 2020 Apr;99(4):229-236
pubmed: 32079025
JAMA Facial Plast Surg. 2014 Mar-Apr;16(2):120-6
pubmed: 24357046
Anaesth Intensive Care. 2002 Oct;30(5):633-40
pubmed: 12413266
Eur Arch Otorhinolaryngol. 2006 Dec;263(12):1127-30
pubmed: 17021782
Eur Arch Otorhinolaryngol. 2020 May;277(5):1437-1448
pubmed: 31982945
JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):143-9
pubmed: 24370595
Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):78-84
pubmed: 14515083
Acta Otorhinolaryngol Ital. 2015 Dec;35(6):400-5
pubmed: 26900245
Laryngoscope. 2014 May;124(5):1150-63
pubmed: 24122657
Head Neck. 2015 Sep;37(9):1233-8
pubmed: 24801433
Ann Thorac Surg. 2010 Nov;90(5):1674-81
pubmed: 20971288
J Otolaryngol. 1998 Jun;27(3):136-40
pubmed: 9664242
Ann Otol Rhinol Laryngol. 1978 Mar-Apr;87(2 Pt 1):159-62
pubmed: 417655
HNO. 2019 Jun;67(Suppl 2):77-79
pubmed: 31053941
J Laryngol Otol. 2018 May;132(5):380-384
pubmed: 29444718
Laryngoscope. 1979 Feb;89(2 Pt 1):250-60
pubmed: 423664
Head Neck. 2021 Aug;43(8):2377-2384
pubmed: 33830587
Surg Endosc. 2008 Aug;22(8):1818-25
pubmed: 18095024
Endoscopy. 2013 Jun;45(6):433-8
pubmed: 23733727
Endosc Int Open. 2015 Dec;3(6):E547-51
pubmed: 26716109
Endoscopy. 2012;44 Suppl 2 UCTN:E49-50
pubmed: 22396274
Eur Arch Otorhinolaryngol. 2019 Jan;276(1):143-151
pubmed: 30426230
ANZ J Surg. 2018 Apr;88(4):E257-E263
pubmed: 27860126
Surg Obes Relat Dis. 2016 Aug;12(7):1278-1285
pubmed: 27178614
Endoscopy. 2010 Sep;42(9):693-8
pubmed: 20806153
Clin Otolaryngol. 2018 Feb;43(1):109-116
pubmed: 28544550
Zentralbl Chir. 2004 May;129 Suppl 1:S7-11
pubmed: 15168274
Am J Clin Dermatol. 2005;6(3):185-94
pubmed: 15943495
Eur Arch Otorhinolaryngol. 2008 Aug;265(8):929-36
pubmed: 18247039
Otolaryngol Head Neck Surg. 2012 Mar;146(3):395-402
pubmed: 22166968
World J Gastroenterol. 2014 Jun 28;20(24):7767-76
pubmed: 24976714
Laryngoscope. 2019 Mar;129(3):671-683
pubmed: 30134500